A functional in vitro assay for screening inhibitors of STAT5B phosphorylation
暂无分享,去创建一个
P. Gunning | Pimyupa Manaswiyoungkul | E. D. de Araujo | Gary Tin | Fettah Erdogan | Abdul K Qadree | K. Toutah | K. Yuen | Diana Sina | Abdul K. Qadree
[1] Jisung Park,et al. High‐throughput thermofluor‐based assays for inhibitor screening of STAT SH2 domains , 2017, Journal of pharmaceutical and biomedical analysis.
[2] J. Matysik,et al. Rational development of Stafib-2: a selective, nanomolar inhibitor of the transcription factor STAT5b , 2017, Scientific Reports.
[3] P. Lai,et al. CD133+ brain tumor-initiating cells are dependent on STAT3 signaling to drive medulloblastoma recurrence , 2016, Oncogene.
[4] M. Geletu,et al. Strategies for over-expression and purification of recombinant full length STAT5B in Escherichia coli. , 2017, Protein expression and purification.
[5] P. Lai,et al. Disarming an Electrophilic Warhead: Retaining Potency in Tyrosine Kinase Inhibitor (TKI)‐Resistant CML Lines While Circumventing Pharmacokinetic Liabilities , 2016, ChemMedChem.
[6] V. Kanelis,et al. Phosphorylation-dependent Changes in Nucleotide Binding, Conformation, and Dynamics of the First Nucleotide Binding Domain (NBD1) of the Sulfonylurea Receptor 2B (SUR2B)* , 2015, The Journal of Biological Chemistry.
[7] T. Berg,et al. Nanomolar Inhibitors of the Transcription Factor STAT5b with High Selectivity over STAT5a , 2015, Angewandte Chemie.
[8] V. Kanelis,et al. Successful development and use of a thermodynamic stability screen for optimizing the yield of nucleotide binding domains. , 2014, Protein expression and purification.
[9] David E. Muench,et al. Nanomolar-Potency Small Molecule Inhibitor of STAT5 Protein , 2014, ACS medicinal chemistry letters.
[10] B. Garcia,et al. Stable Isotope Labeling of Phosphoproteins for Large-scale Phosphorylation Rate Determination* , 2014, Molecular & Cellular Proteomics.
[11] A. Maitra,et al. APE1/Ref-1 Regulates STAT3 Transcriptional Activity and APE1/Ref-1–STAT3 Dual-Targeting Effectively Inhibits Pancreatic Cancer Cell Survival , 2012, PloS one.
[12] J. Glickman. Assay Development for Protein Kinase Enzymes , 2012 .
[13] G. Superti-Furga,et al. BCR-ABL uncouples canonical JAK2-STAT5 signaling in chronic myeloid leukemia. , 2012, Nature chemical biology.
[14] P. Hodder,et al. Modulators of STAT Transcription Factors for the Targeted Therapy of Cancer (STAT3 Inhibitors) , 2011 .
[15] Yu Xue,et al. GPS 2.1: enhanced prediction of kinase-specific phosphorylation sites with an algorithm of motif length selection. , 2011, Protein engineering, design & selection : PEDS.
[16] J. Mestan,et al. In vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutants. , 2005, Cancer research.
[17] T. Berg,et al. A high-throughput fluorescence polarization assay for signal transducer and activator of transcription 3. , 2004, Analytical biochemistry.
[18] C. Austin,et al. Assay Development for Protein Kinase Enzymes -- Assay Guidance Manual , 2004 .
[19] Wayne F. Patton,et al. Global quantitative phosphoprotein analysis using Multiplexed Proteomics technology , 2003, Proteomics.
[20] Matthew B. Wilson,et al. The Src family kinase Hck couples BCR/ABL to STAT5 activation in myeloid leukemia cells , 2002, The EMBO journal.
[21] J. Darnell,et al. Signalling: STATs: transcriptional control and biological impact , 2002, Nature Reviews Molecular Cell Biology.